MYLUNG Study Launches, Aiming to Advance Use of Precision Medicine for Metastatic Non-Small Cell Lung Cancer Patients

Unique, collaborative real-world research consortium will study up to 12,000 NSCLC patients in the community setting over five yearsMYLUNG to deepen understanding of barriers and address challenges to improve care for lung cancer patients, including those with targetable mutations
Source: McKesson News - Category: Information Technology Source Type: news